Ionis Pharmaceuticals | IONS - Sales Revenues



Ionis Pharmaceuticals reported $452M in Sales Revenues for its fiscal quarter ending in June of 2025.


Sales Change Date
Adcock Ingram Holdings ZAR 4.71B 188.47M Dec/2024
Agios Pharmaceuticals USD 12.45M 3.75M Jun/2025
Alnylam Pharmaceuticals USD 773.69M 179.5M Jun/2025
Arrowhead Research USD 27.77M 514.94M Jun/2025
Astellas Pharma JPY 505.79B 46.5B Jun/2025
BioMarin Pharmaceutical USD 825M 80M Jun/2025
Celltrion KRW 961.51B 119.6B Jun/2025
Cspc Pharmaceutical CNY 7.01B 691.61M Mar/2025
Divis Laboratories Ltd 24.1B 1.75B Jun/2025
Exelixis USD 568.3M 12.9M Jun/2025
Halozyme Therapeutics USD 206M 59M Jun/2025
Ionis Pharmaceuticals USD 452M 320M Jun/2025
Kangmei Pharma CNY 1.27B 32.4M Jun/2025
Knight Therapeutics CAD 92.26M 3.31M Sep/2024
Laboratorios Farma 159.7M 274.71M Jun/2025
Malin Corporation EUR 19.2M 2.6M Dec/2020
Medical Developments International AUD 7.54M 0 Dec/2023
Moderna USD 142M 34M Jun/2025
Neuren Pharmaceuticals AUD 194.1M 163.93M Dec/2024
Neurocrine Biosciences USD 687.5M 114.9M Jun/2025
Novartis USD 14.05B 821M Jun/2025
OPKO Health USD 156.81M 26.79M Jun/2025
Organigram Holdings CAD 70.79M 28.06M Jun/2025
Pfizer USD 14.7B 980M Jun/2025
Pharma Mar EUR 56.39M 17.49M Jun/2025
PTC Therapeutics USD 178.9M 11.1M Jun/2025
Qiagen NV USD 533.54M 108.24M Jun/2025
Regeneron Pharmaceuticals USD 3.68B 650M Jun/2025
Roche Holding CHF 31.64B 883M Dec/2024
Sarepta Therapeutics USD 611.09M 163.81M Jun/2025
Sartorius EUR 884.3M 1.3M Jun/2025
Sino Biopharmaceutical CNY 17.57B 1.7B Jun/2025
Tilray USD 308.01M 43.78M Jun/2025
Ultragenyx Pharmaceutical USD 166.5M 27.21M Jun/2025
Vertex Pharmaceuticals USD 2.96B 190M Jun/2025
Zhangzhou Pientzehuang Pharmaceutical 2.24B 902.99M Jun/2025